microarray-based breast cancer test (Agendia BV)
Structured Review
Microarray Based Breast Cancer Test, supplied by Agendia BV, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/agilent-based+microarray+platform/microarray+based+breast+cancer+test/us07592138-182-4-0
Average 90 stars, based on 1 article reviews
Images
Related Articles
Diagnostic Assay:Article Title: New Members of the Editorial Board ‐ Personal Profiles Article Snippet: .. In July of 2003 he co‐founded “Agendia”, a genomics‐based diagnostic company that started offering the first microarray‐based diagnostic test for the clinical management of Microarray:Article Title: New Members of the Editorial Board ‐ Personal Profiles Article Snippet: .. In July of 2003 he co‐founded “Agendia”, a genomics‐based diagnostic company that started offering the first microarray‐based diagnostic test for the clinical management of other:Article Title: Identification of a gene expression profile that differentiates ischemic and nonischemic cardiomyopathy Article Snippet: |
